Organo (TSE:6368) Total Current Liabilities: 円70,939 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:6368 Organo Corp TSE:6368
91 GF Score
Price 円13,535.00
GF Value 円9,391.73
Valuation Significantly Overvalued
View Full Analysis

What is Organo Total Current Liabilities?

Organo TSE:6368 -9.77% 91 Total Current Liabilities is 円70,939 Mil as of Mar. 2026. GuruFocus rates TSE:6368 with a GF Score™ of 91/100 and a GF Value™ of 円9,391.73 (Significantly Overvalued).

Total current liabilities includes Accounts Payable & Accrued Expense, Short-Term Debt & Capital Lease Obligation, Other Current Liabilities, and Current Deferred Liabilities. Organo's total current liabilities for the quarter that ended in Mar. 2026 was 円70,939


Be Aware

Stay away from companies that roll over the debt e.g. Bear Stearns

When investing in financial institutions, Buffett shies from those who are bigger borrowers of short term than long term debt.

His favorite Wells Fargo has 57 cents short term debt for every dollar of long term.

Aggressive banks (like Bank of America) has $2.09 short term for every dollar long term


Organo Total Current Liabilities Related Terms


Organo Total Current Liabilities Historical Data

* Premium members only.

The historical data trend for Organo's Total Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Organo Total Current Liabilities Chart

Organo Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Total Current Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 43,072.00 68,738.00 72,602.00 64,401.00 70,939.00

Organo Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 64,401.00 57,368.00 53,571.00 64,234.00 70,939.00
TSE:6368
91GF Score
Organo Corp TSE:6368
Total Current Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Organo Total Current Liabilities Calculation

Total Current Liabilities is the total amount of liabilities that the company needs to pay over the next 12 months.

Organo's Total Current Liabilities for the fiscal year that ended in Mar. 2026 is calculated as

Total Current Liabilities=Accounts Payable & Accrued Expense+Short-Term Debt & Capital Lease Obligation
=26465+28402
+Other Current Liabilities+Current Deferred Liabilities
=16072+0
=70,939

Organo's Total Current Liabilities for the quarter that ended in Mar. 2026 is calculated as

Total Current Liabilities=Accounts Payable & Accrued Expense+Short-Term Debt & Capital Lease Obligation
=26465+28402
+Other Current Liabilities+Current Deferred Liabilities
=16072+0
=70,939

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The increase of Total Current Liabilities of a company is not necessarily a bad thing. This may conserve the company's cash and contribute positively to cash flow.

Total Current Liabilities is linked to Total Current Assets through the Current Ratio and Working Capital. The Current Ratio is equal to dividing total current assets by total current liabilities. It is frequently used as an indicator of a company's liquidity, its ability to meet short-term obligations. Net working capital is calculated as Total Current Assets minus Total Current Liabilities.

What does a Total Current Liabilities of 円70,939 Mil mean?
Organo (TSE:6368) has a Total Current Liabilities of 円70,939 Mil as of Mar. 2026. The total amount of liabilities with maturity less than one year as recorded on a company's balance sheet. View historical data for Organo and its competitors.
Is Organo's Total Current Liabilities too high?
Organo's current Total Current Liabilities is 円70,939 Mil. Overall, Organo has a GF Score™ of 91/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Organo's Total Current Liabilities compare to VLTO and ZWS?
Organo's Total Current Liabilities of 円70,939 Mil can be compared against companies in the Industrial Products industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Current Liabilities for an Industrial Products company?
A good Total Current Liabilities depends on the Industrial Products industry context. However, Total Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Current Liabilities mean?
A high Total Current Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities with maturity less than one year as recorded on a company's balance sheet. View historical data for Organo and its competitors. Organo's current Total Current Liabilities is 円70,939 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Organo stock overvalued right now?
Based on GuruFocus' analysis, Organo (TSE:6368) is currently considered Significantly Overvalued. The stock's GF Value™ is 円9,391.73, compared to a current price of 円13,535.00 — trading 44.1% above its estimated fair value. The current Total Current Liabilities is 円70,939 Mil. Organo's overall GF Score™ is 91/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Current Liabilities calculated?
Total Current Liabilities is calculated from a company's financial statements. For Organo (TSE:6368), the current Total Current Liabilities is 円70,939 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Organo (TSE:6368) Overvalued in 2026?

Based on GuruFocus' analysis, Organo stock appears to be overvalued. The current stock price of 円13,535.00 is trading 44.1% above its estimated GF Value™ of 円9,391.73. GuruFocus considers Organo to be Significantly Overvalued.

Key valuation signals for TSE:6368:

  • Total Current Liabilities: 円70,939 Mil
  • GF Value™: 円9,391.73 vs. price of 円13,535.00 (44.1% above fair value)
  • GF Score™: 91/100

No single metric tells the full story. See the TSE:6368 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Organo Business Description

Other Exchanges ORGJF:USA
Address 1-2-8 Shinsuna, Koto-ku, Tokyo, JPN, 136-8631
Organo Corp is a Japan-based company mainly engaged in the water treatment engineering business. The company operates in two business divisions namely water treatment engineering and functional product. Its water treatment engineering business includes manufacturing, delivery and maintenance of pure water systems, ultra-pure water systems and wastewater treatment systems for industries, condensate de mineralizers for power stations, waterworks and sewage treatment systems for the public sector. The functional product business encompasses the sale of standardized water treatment equipment, water treatment chemicals, and food processing materials.
91GF Score

Get the complete analysis for TSE:6368

Total Current Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円13,535.00
Price
円9,391.73
GF Value